MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy.
Saved in:
| Title: | MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy. |
|---|---|
| Authors: | Constanzo, Julie1 (AUTHOR) julie.constanzo@inserm.fr, Parach, Aliasghar1 (AUTHOR), David, Timothee1 (AUTHOR), Karam, Joshua1 (AUTHOR), Bruchertseifer, Frank2 (AUTHOR), Morgenstern, Alfred2 (AUTHOR), Jarlier, Marta3 (AUTHOR), Bardiès, Manuel1 (AUTHOR), Deshayes, Emmanuel1 (AUTHOR), Gudin-de-Vallerin, Amelie4 (AUTHOR), Boissière-Michot, Florence4 (AUTHOR), Lopez-Crapez, Evelyne4 (AUTHOR), Pouget, Jean-Pierre1 (AUTHOR) jean-pierre.pouget@inserm.fr |
| Source: | Journal of Nuclear Medicine. May2025, Vol. 66 Issue 5, p785-792. 8p. |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
